作者:
Beth A,Helmink [1]
;
Sangeetha M,Reddy [2]
;
Jianjun,Gao [3]
;
Shaojun,Zhang [4]
;
Rafet,Basar [5]
;
Rohit,Thakur [6]
;
Keren,Yizhak [7]
;
Moshe,Sade-Feldman [7]
;
Jorge,Blando [8]
;
Guangchun,Han [9]
;
Vancheswaran,Gopalakrishnan [4]
;
Yuanxin,Xi [6]
;
Hao,Zhao [10]
;
Rodabe N,Amaria [9]
;
Hussein A,Tawbi [11]
;
Alex P,Cogdill [11]
;
Wenbin,Liu [6]
;
Valerie S,LeBleu [9]
;
Fernanda G,Kugeratski [12]
;
Sapna,Patel [12]
;
Michael A,Davies [11]
;
Patrick,Hwu [11]
;
Jeffrey E,Lee [11]
;
Jeffrey E,Gershenwald [6]
;
Anthony,Lucci [6]
;
Reetakshi,Arora [6]
;
Scott,Woodman [4]
;
Emily Z,Keung [11]
;
Pierre-Olivier,Gaudreau [6]
;
Alexandre,Reuben [6]
;
Christine N,Spencer [13]
;
Elizabeth M,Burton [14]
;
Lauren E,Haydu [6]
;
Alexander J,Lazar [6]
;
Roberta,Zapassodi [4]
;
Courtney W,Hudgens [15]
;
Deborah A,Ledesma [16]
;
SuFey,Ong [17]
;
Michael,Bailey [15]
;
Sarah,Warren [15]
;
Disha,Rao [18]
;
Oscar,Krijgsman [18]
;
Elisa A,Rozeman [18]
;
Daniel,Peeper [19]
;
Christian U,Blank [19]
;
Ton N,Schumacher [19]
;
Lisa H,Butterfield [19]
;
Monika A,Zelazowska [19]
;
Kevin M,McBride [19]
;
Raghu,Kalluri [20]
;
James,Allison [21]
;
Florent,Petitprez [21]
;
Wolf Herman,Fridman [12]
;
Catherine,Sautès-Fridman [9]
;
Nir,Hacohen [22]
;
Katayoun,Rezvani [23]
;
Padmanee,Sharma [24]
;
Michael T,Tetzlaff [22]
;
Linghua,Wang [23]
;
Jennifer A,Wargo [22]
作者单位:
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. bhelmink@mdanderson.org.
[1]
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[2]
Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[3]
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[4]
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[5]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[6]
Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
[7]
Broad Institute of the Massachusetts Institute of Technology, Boston, MA, USA.
[8]
Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[9]
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[10]
Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[11]
Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[12]
Department of Thoracic / Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[13]
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.
[14]
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[15]
Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[16]
Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[17]
Nanostring Technologies, Seattle, WA, USA.
[18]
Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
[19]
Departments of Medicine, Surgery, Immunology and Clinical and Translational Science, University of Pittsburgh, Pittsburgh, PA, USA.
[20]
Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
[21]
INSERM, Cordeliers Research Center, Team Cancer, Immune Control and Escape, Paris, France.
[22]
University Paris Descartes Paris 5, Sorbonne Paris Cite, Centre de Recherche des Cordeliers, Paris, France.
[23]
Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France.
[24]
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
[25]
Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwargo@mdanderson.org.
[26]
主题词
B-淋巴细胞(B-Lymphocytes);癌, 肾细胞(Carcinoma, Renal Cell);克隆细胞(Clone Cells);树突细胞, 滤泡(Dendritic Cells, Follicular);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);免疫记忆(Immunologic Memory);免疫疗法(Immunotherapy);质谱分析法(Mass Spectrometry);黑色素瘤(Melanoma);肿瘤转移(Neoplasm Metastasis);表型(Phenotype);预后(Prognosis);受体, 免疫(Receptors, Immunologic);单细胞分析(Single-Cell Analysis);T淋巴细胞(T-Lymphocytes)
DOI
10.1038/s41586-019-1922-8
PMID
31942075
发布时间
2022-07-15
- 浏览125

Nature
Nature
549-555页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文